US Supplement Industry Growth Robust, But Stronger With Regulatory Help– NBJ Founder
Executive Summary
Businesses offering products with undisclosed drugs or labeled with violative claims and the absence of a federal regulation on lawful use of hemp ingredients in supplements are impediments to growth, says Thomas Aarts, NBJ founder currently managing director of Nutrition Business Advisors.
You may also be interested in...
CBD Will Be US FDA’s ‘One’ Lawful Hemp Compound, House Appropriators Anticipate
Reference in report accompanying House Appropriation Committee bill for FDA FY2023 budget isn’t binding and wasn’t appropriators’ first mention of agency’s response to de-scheduling hemp as a controlled substance. But their ’ statement was more pointed than in previous appropriation reports.
From: US FDA; To: Supplement Industry – Tis The Season To Note Disease Claims, Undeclared Drugs
FDA wraps end-of-year greetings to supplement industry about drug-spiked products labeled as supplements in a bow with officials sharing annual update of their oversight of the industry during a food and drug regulation gathering.
Consumer E-commerce Comfort Helps Amazon Health Product Sales Jump 50%
Amazon’s nutrition and wellness sales soared 55% in 2018 to around $2.5bn and health product sales, including OTC drugs, jumped 50% to about $600m, as consumers grow more comfortable purchasing health products online, says e-commerce market research firm Edge by Ascential.